https://www.selleckchem.com/pr....oducts/etomoxir-na-s
Finally, 155 patients were stratified into favorable- and unfavorable-risk groups based on the numbers of the predictive factors. The overall survival (OS) in the unfavorable-risk group (total scores 2-3) was significantly worse than that of the favorable-risk group (total score 0-1) (P=0.02). This prognostic model was assessed with 50 low-risk mHSPC patients from the external validation dataset and found both the time to CRPC, and the OS in the unfavorable-risk group was significantly worse than that of the favorable-risk grou
Like
Comment
Share
